Phase 4 Type 1 Diabetes Trial, Recruiting (NCT05454176)

Phase 4 Type 1 Diabetes Trial, Recruiting NCT05454176 Sponsor: University of Minnesota Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT05454176 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children and young people living in Uganda, between 4 and 26 years old at the start of the study
People who have been diagnosed with Type 1 diabetes based on clinical assessment, for at least 12 months before the study begins
People who are currently using insulin to manage their diabetes
People who have access to a cell phone
For participants under 18 years old, at least one parent or guardian must be present at the clinic and able to give consent on their behalf; those aged 18 to 26 may give consent for themselves

Who may not be able to join:

People who are unwilling or unable to attend the pediatric diabetes clinic on a monthly basis
People who are pregnant, breastfeeding, or likely to become pregnant within the next year
People with serious medical conditions that, in the opinion of the study investigator, could interfere with taking part in the study
People who already use a continuous glucose monitor (CGM) device
People who are unable to wear the study sensor for at least 7 days during the baseline period, or are unable to return it
People who the study team considers unlikely or unable to follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Antoinette Moran, University of Minnesota

Phone: 612-624-2922

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05454176

Sponsor: University of Minnesota

Phase: Phase 4

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 612-624-2922

More information: https://clinicaltrials.gov/study/NCT05454176

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children and young people living in Uganda, between 4 and 26 years old at the start of the study
People who have been diagnosed with Type 1 diabetes based on clinical assessment, for at least 12 months before the study begins
People who are currently using insulin to manage their diabetes
People who have access to a cell phone
For participants under 18 years old, at least one parent or guardian must be present at the clinic and able to give consent on their behalf; those aged 18 to 26 may give consent for themselves

Who may not be able to join:

People who are unwilling or unable to attend the pediatric diabetes clinic on a monthly basis
People who are pregnant, breastfeeding, or likely to become pregnant within the next year
People with serious medical conditions that, in the opinion of the study investigator, could interfere with taking part in the study
People who already use a continuous glucose monitor (CGM) device
People who are unable to wear the study sensor for at least 7 days during the baseline period, or are unable to return it
People who the study team considers unlikely or unable to follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

15 August 2022

Est. completion

15 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Glucose Time-in-Range; Cost analysis of CGM

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov